Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 30 Mar 2026 for Knight Therapeutics Inc., €22k.
Filing timeline
BuySaleCristiane Zanqueta Coelho Peev
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Cristiane Zanqueta Coelho Peev: trading record in brief
This profile gathers the share dealings of Cristiane Zanqueta Coelho Peev in Knight Therapeutics Inc. The record holds 6 filings, for trades running from 24 January 2022 to 26 March 2026.
Every open-market trade on record is a sale: 1 sale worth €22k. Outside the open market, there are 3 share grants and 1 option exercise. In 2026 alone, the filings show no purchases and 1 sale.
The newest entry dates from 30 March 2026: an open-market sale of €22k, in Knight Therapeutics Inc. Filings reach the SEDI feed a median of 4 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Companies and markets linked to Cristiane Zanqueta Coelho Peev
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
4,938 shares@ CA$7.0937.0% of flowCommon SharesTSXSEDI:4691622
7,668 shares@ CA$6.4152.4% of flowCommon SharesTSXSEDI:4690387
456 shares@ CA$6.1728.7% of flowCommon SharesTSXSEDI:4685687
868 shares@ CA$6.39100.0% of flowCommon SharesTSXSEDI:4576758
Common SharesTSXSEDI:4376688
262 shares@ CA$5.9023.1% of flowCommon SharesTSXSEDI:4376691
6 of 6 declarations
